Sirolimus eluting stent clinical trials Drug eluting stent

CYPHER

Acute myocardial infarction

All type of patients:  8 trials  - DEBATER (SES vs BMS) - Juwana - MISSION - Díaz de la Llera - SESAMI - PROSIT - TYPHOON - Di Lorenzo et al.

Coronary artery disease

Acute myocardial infarction:  7 trials  - DEBATER (SES vs BMS) - MISSION - SORT OUT II - Díaz de la Llera - SESAMI - PROSIT - TYPHOON

All type of patient:  48 trials  - PRECOMBAT - GISSOC II - ISAR-LEFT-MAIN - Thiele - BASKET-PROVE - MISSION - SORT OUT II - Tomai - Kochiadakis - Ortolani et al - Pan - Petronio et al - SCORPIUS - SESAMI - Cervinka - Han - ISAR-SMART 3 - ISAR-TEST-1 - LONG DES II - PRISON II - PROSIT - REALITY - SCANDSTENT - TYPHOON - Zhang (SES vs PES) - BASKET (vs paclitaxel) - CORPAL - DECODE - Di Lorenzo et al. - DIABETES - ISAR-DESIRE (SES vs PES) - ISAR-DESIRE (SES vs PTCA) - ISAR-DIABETES - Pache et al - SIRTAX (Windecker) - TAXi - C-SIRIUS - SES-SMART - E-SIRIUS - Pasceri - SIRIUS - RAVEL - DES-ISR - FOCUS - Lipsia-Yukon-DM - MIDCAB Versus DES in Proximal LAD Lesions - Munich Study - Gao

All type of patients:  52 trials  - PRECOMBAT - BASKET-PROVE (SES) - GISSOC II - DEBATER (SES vs BMS) - ISAR-LEFT-MAIN - Thiele - BASKET-PROVE - DES-DIABETES - Kim - MISSION - SORT OUT II - Tomai - Kochiadakis - Ortolani et al - Pan - Petronio et al - SCORPIUS - SESAMI - Cervinka - Han - ISAR-SMART 3 - ISAR-TEST-1 - LONG DES II - PRISON II - PROSIT - REALITY - SCANDSTENT - TYPHOON - Zhang (SES vs PES) - BASKET (vs paclitaxel) - CORPAL - DECODE - Di Lorenzo et al. - DIABETES - ISAR-DESIRE (SES vs PES) - ISAR-DESIRE (SES vs PTCA) - ISAR-DIABETES - Pache et al - SIRTAX (Windecker) - TAXi - C-SIRIUS - SES-SMART - E-SIRIUS - Pasceri - SIRIUS - RAVEL - DES-ISR - FOCUS - Lipsia-Yukon-DM - MIDCAB Versus DES in Proximal LAD Lesions - Munich Study - Gao

Bifurcation lesion:  1 trials  - Pan

Bypass graft lesion:  1 trials  - RRISC

Diabetic patients :  14 trials  - TAxi (diabetics) - DES-DIABETES - DESSERT - Kim - Tomai - REALITY (diabetics) - DECODE - DIABETES - ISAR-DIABETES - SES-SMARt (diabetics) - SIRTAX diabetics - Ravel (diabetics) - SIRIUS (diabetics) - Lipsia-Yukon-DM

In stent restenosis:  7 trials  - ISAR-DESIRE-2 - RIBS-II - SISR - ISAR-DESIRE (SES vs PES) - CRISTAL - DES-ISR - FOCUS

Long or complex lesion:  4 trials  - LONG DES II - PRISON II - SCANDSTENT - CORPAL

Single vessel disease:  1 trials  - Thiele

Small vessels:  3 trials  - ISAR-SMART 3 - SIRTAX (small vessels subgroup) - SES-SMART

Total occlusion:  3 trials  - GISSOC II - PRISON II - SCANDSTENT (subgroup)

Unparticular patients:  20 trials  - BASKET-PROVE - SORT OUT II - Wessely - Kochiadakis - Ortolani et al - Han - ISAR-TEST-1 - REALITY - Zhang (SES vs PES) - BASKET (vs paclitaxel) - Pache et al - SIRTAX (Windecker) - TAXi - C-SIRIUS - E-SIRIUS - SIRIUS - RAVEL - MIDCAB Versus DES in Proximal LAD Lesions - Munich Study - Gao

Unprotected left main artery stenosis:  1 trials  - ISAR-LEFT-MAIN

Stable angina

All type of patient:  38 trials  - GISSOC II - ISAR-LEFT-MAIN - Thiele - Kim - Tomai - Kochiadakis - Ortolani et al - Petronio et al - SCORPIUS - Cervinka - Han - ISAR-SMART 3 - ISAR-TEST-1 - LONG DES II - PRISON II - REALITY - SCANDSTENT - Zhang (SES vs PES) - BASKET (vs paclitaxel) - CORPAL - DECODE - Di Lorenzo et al. - DIABETES - ISAR-DESIRE (SES vs PES) - ISAR-DIABETES - Pache et al - SIRTAX (Windecker) - TAXi - C-SIRIUS - SES-SMART - E-SIRIUS - Pasceri - SIRIUS - RAVEL - DES-ISR - FOCUS - Lipsia-Yukon-DM - MIDCAB Versus DES in Proximal LAD Lesions

Diabetic patients :  2 trials  - DESSERT - Kim

Single vessel disease:  1 trials  - Thiele